A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69. - Woods, M; Guy, R; Waldmann, H; Glennie, M; Alexander, DR (Cellular immunology, 1998)